Population Pharmacokinetics of Itraconazole and its Active Metabolite Hydroxy-Itraconazole in Paediatric Cystic Fibrosis and Bone Marrow Transplant Patients

By Hennig Stefanie   Wainwright Claire E.   Bell Scott C.   Miller Hugh   Friberg Lena E.   Charles Bruce G.  

Clinical Pharmacokinetics, Vol. 45, Iss. 11, 2006-01 ,pp. : 1099-1114

Adis International

Access to resources Recommend Favorite

Optimal Design Criteria for Discrimination and Estimation in Nonlinear Models

By Waterhouse T. H.  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 2, 2009-03 ,pp. : 386-402

Taylor & Francis Ltd

Access to resources Recommend Favorite

Optimal Blood Sampling Time Windows for Parameter Estimation Using a Population Approach: Design of a Phase II Clinical Trial

By Chenel Marylore   Ogungbenro Kayode   Duval Vincent   Laveille Christian   Jochemsen Roeline   Aarons Leon  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 32, Iss. 5-6, 2005-12 ,pp. : 737-756

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics of Ibuprofen in Children with Cystic Fibrosis

By Han E.E.   Beringer P.M.   Louie S.G.   Gill M.A.   Shapiro B.J.  

Clinical Pharmacokinetics, Vol. 43, Iss. 3, 2004-01 ,pp. : 145-156

Adis International

Access to resources Recommend Favorite

Simultaneous optimal experimental design for in vitro binding parameter estimation

By Ernest C.   Karlsson Mats   Hooker Andrew  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 40, Iss. 5, 2013-10 ,pp. : 573-585

Springer Publishing Company

Access to resources Recommend Favorite